Minimally Invasive Surgery Market Report 2025

This Minimally Invasive Surgery market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The minimally invasive surgery market size has grown strongly in recent years. It will grow from $63.82 billion in 2024 to $69.89 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to patient awareness, reduced hospital stay, lower infection risk, surgeon training and proficiency, chronic disease prevalence.

The minimally invasive surgery market size is expected to see strong growth in the next few years. It will grow to $100.45 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to government initiatives, aging population, remote surgery, lower infection risk, patient-centric care. Major trends in the forecast period include virtual reality (vr) training, artificial intelligence (ai)-assisted surgery, nanotechnology, 3D printing, data security.

The increasing prevalence of chronic diseases is expected to drive demand for the minimally invasive surgery market. Chronic diseases are persistent illnesses often incurable but sometimes manageable. Lifestyle changes, poor dietary habits, and weight mismanagement contribute to chronic conditions, with prolonged infections increasing the risk of cancer. The growing incidence of these diseases necessitates minimally invasive surgery for patients, offering benefits such as reduced post-operative pain, fewer complications, shorter hospital stays, faster recovery, less scarring, and lower stress on the immune system. For instance, a January 2023 report from the National Library of Medicine projects a 99.5% increase in individuals aged 50 and older with one or more chronic illnesses by 2050 in the United States, reaching 142.66 million, up from 71.522 million in 2020. Consequently, the rising prevalence of chronic diseases is propelling the growth of the minimally invasive surgery market.

The increasing prevalence of cardiovascular diseases is expected to contribute to the growth of the minimally invasive surgery market. Cardiovascular diseases (CVD) encompass conditions affecting the heart or blood vessels, often associated with atherosclerosis and an elevated risk of blood clots. Minimally invasive surgeries are utilized in cardiovascular disease treatment to lower the risk of complications, reduce blood loss, minimize infection risk, and improve visualization. According to a January 2023 report from the American Heart Association, CVD accounted for approximately 19.1 million deaths worldwide in 2020. The rising incidence of cardiovascular diseases globally is anticipated to drive the growth of the minimally invasive surgery market.

Major companies in the minimally invasive surgery market are creating technologically advanced products, such as navigation systems, to enhance surgical precision, improve patient safety, and shorten recovery times. A navigation system is a technology that identifies a vehicle's or individual's position and directs them to a desired destination using maps, sensors, and satellite-based tools like GPS. For instance, in August 2023, Orthofix Medical Inc., a US-based medical device firm, introduced the 7D FLASH Navigation System Percutaneous Module 2 for minimally invasive surgery. This launch improves the clinical capabilities and utility of the 7D FLASH Navigation System by providing surgeons with a fully integrated solution for minimally invasive surgery (MIS), including implant planning and a wider range of navigated tools. The new application focuses on the crucial MIS spine navigation market and enhances the 7D FLASH Navigation System's attractiveness as the preferred option for various institutions, from teaching hospitals to ambulatory surgery centers.

Major companies in the minimally invasive surgery market are creating technologically advanced products, such as miniaturized robotic-assisted surgery (miniRAS) devices, to provide customers with enhanced features. A miniaturized robotic-assisted surgery (miniRAS) device is a compact surgical system that improves precision and control during minimally invasive procedures by using robotic technology and smaller instruments to conduct complex surgeries with minimal incisions. For example, in February 2024, Virtual Incision Corporation, a US-based medical device firm, announced that its MIRA Surgical System (MIRA) received approval from the U.S. Food and Drug Administration (FDA). The miniRAS device is specifically designed for adults undergoing colectomy procedures. MIRA incorporates an innovative tray-to-table design that enables healthcare facilities to utilize robotic surgery without needing to restructure the operating room around the device, which is a significant challenge with traditional mainframe surgical robots. Weighing approximately two pounds (less than one kg), MIRA's compact and portable design reduces setup time, allowing any operating room to be prepared for robotic surgery in just minutes.

In September 2024, Stryker, a US-based medical device company, acquired NICO Corporation for an undisclosed amount. This strategic acquisition enhances Stryker's position as a global leader in neurosurgical access and removal tools, enabling the company to offer unique, minimally invasive solutions that can deliver significant results and improve the quality of life for patients worldwide. NICO Corporation is a US-based provider of minimally invasive surgery devices.

Major companies operating in the minimally invasive surgery market include Arthrex Inc., B. Braun Melsungen AG, Intuitive Surgical Inc., Medtronic Inc., OmniGuide Inc., Olympus Corporation, GE Healthcare, Siemens Healthineers, Smith & Nephew, Johnson & Johnson Ltd., Stryker Corporation, Boston Scientific Corporation, Abbott Laboratories, Koninklijke Philips N.V., Applied Medical Resources Corporation, KLS Martin Group, Scanlan International Inc., Wexler Surgical, STRAUSS SURGICAL, AMNOTEC International Medical GmbH, EndoMed Systems GmbH, TROKAMED GmbH, Surgical Holdings Ltd., Ethicon Inc., DePuy Synthes, NuVasive Inc., Zimmer Biomet Holdings Inc., Renishaw plc, CONMED Corporation, Bedfordshire Hospitals NHS Foundation Trust, Manipal Health Enterprises Pvt. Ltd., Singapore General Hospital Ltd., The General Hospital Corporation, Karl Storz SE & Co. KG, Becton Dickinson and Company, Applied Medical Resources Corporation, LiNA Medical, HOYA Corporation, Steris Corporation.

North America was the largest region in the minimally invasive surgery market in 2024. The regions covered in the minimally invasive surgery market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the minimally invasive surgery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

Minimally invasive surgery involves conducting surgical procedures on the body with reduced damage compared to open surgery. Surgeons employ small tools, cameras, and lights that can fit through small incisions in the skin during these procedures. The primary objectives of minimally invasive surgery are to minimize postoperative pain and blood loss, hasten recovery, and diminish scarring.

The essential devices used in minimally invasive surgery include handheld instruments, inflation devices, cutter instruments, guiding devices, electrosurgical devices, auxiliary devices, and monitoring and visualization devices. Handheld instruments play a crucial role in enhancing dexterity, precision, and ergonomics during the procedure. This category encompasses any portable instrument small enough to be held in one's hand. Minimally invasive surgery products include surgical devices, laparoscopy devices, and monitoring and visualization devices applied across various medical fields such as cardiac, gastrointestinal, orthopedic, vascular, gynecological, urological, cosmetic, and dental. These products find application in hospitals, specialty clinics, and ambulatory surgery centers.

The minimally invasive surgery market research report is one of a series of new reports that provides minimally invasive surgery market statistics, including minimally invasive surgery industry global market size, regional shares, competitors with a minimally invasive surgery market share, detailed minimally invasive surgery market segments, market trends and opportunities, and any further data you may need to thrive in the minimally invasive surgery industry. This minimally invasive surgery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The minimally invasive surgery market includes revenues earned by entities by laparoscopic surgery, robotic surgery, endoscopic mucosal resection, endoscopic submucosal dissection, and transcatheter. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.